Commentary on Knight et al.: A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors.
Department of Clinical Pharmacy, Pharmaceutical Economics and Policy, University of Southern California, 1540 E Alcazar St, Los Angeles, CA 90089, USA. jhay@usc.edu
